{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:04:29Z","timestamp":1782691469141,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jad-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.jad.2015.08.040","type":"journal-article","created":{"date-parts":[[2015,8,21]],"date-time":"2015-08-21T01:33:47Z","timestamp":1440120827000},"page":"142-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Depression and hypomania symptoms are associated with high dose corticosteroids treatment for MS relapses"],"prefix":"10.1016","volume":"187","author":[{"given":"Sarah Anne","family":"Morrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Rosehart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Ulch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jad.2015.08.040_bib1","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/jnnp.2004.045518","article-title":"Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves","volume":"76","author":"Achiron","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2015.08.040_bib2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00296-007-0410-x","article-title":"Acute psychosis in systemic lupus erythematosus","volume":"28","author":"Appenzeller","year":"2008","journal-title":"Rheumatol. Int."},{"issue":"5","key":"10.1016\/j.jad.2015.08.040_bib3","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1191\/1352458505ms1192oa","article-title":"Regional variation of multiple sclerosis prevalence in Canada","volume":"11","author":"Beck","year":"2005","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.jad.2015.08.040_bib4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1191\/1352458503ms902oa","article-title":"Validity of the beck depression inventory-fast screen in multiple sclerosis","volume":"9","author":"Benedict","year":"2003","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.jad.2015.08.040_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4088\/PCC.v03n0104","article-title":"Mood and cognitive changes during systemic corticosteroid therapy","volume":"3","author":"Brown","year":"2001","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2015.08.040_bib6","first-page":"CD006921","article-title":"Oral versus intravenous steroids for treatment of relapses in multiple sclerosis","volume":"12","author":"Burton","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"1 Pt 1","key":"10.1016\/j.jad.2015.08.040_bib7","first-page":"336","article-title":"High- and low-dose prednisolone","volume":"13","author":"Chan","year":"1981","journal-title":"Transplant. Proc."},{"issue":"20","key":"10.1016\/j.jad.2015.08.040_bib8","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJM200011163432001","article-title":"Relapses and progression of disability in multiple sclerosis","volume":"343","author":"Confavreux","year":"2000","journal-title":"New Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jad.2015.08.040_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1176\/jnp.11.1.51","article-title":"Neuropsychiatric manifestations of multiple sclerosis","volume":"11","author":"Diaz-Olavarrieta","year":"1999","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"5","key":"10.1016\/j.jad.2015.08.040_bib10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1191\/1352458504ms1087oa","article-title":"A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic","volume":"10","author":"Edwards","year":"2004","journal-title":"Mult. Scler"},{"issue":"4","key":"10.1016\/j.jad.2015.08.040_bib11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1212\/01.wnl.0000172917.70752.05","article-title":"Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders","volume":"65","author":"Ettinger","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jad.2015.08.040_bib12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1176\/appi.ajp.160.1.178","article-title":"Validity of the mood disorder questionnaire: a general population study","volume":"160","author":"Hirschfeld","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.jad.2015.08.040_bib13","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1176\/appi.ajp.157.11.1873","article-title":"Development and validation of a screening instrument for bipolar spectrum disorder: the mood disorder questionnaire","volume":"157","author":"Hirschfeld","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2015.08.040_bib14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0165-0327(83)90022-8","article-title":"Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature","volume":"5","author":"Lewis","year":"1983","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.jad.2015.08.040_bib15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archpsyc.1981.01780290105011","article-title":"Side effects of corticosteroid therapy. Psychiatric aspects","volume":"38","author":"Ling","year":"1981","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2015.08.040_bib16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/1352458508099477","article-title":"The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated","volume":"15","author":"Marrie","year":"2009","journal-title":"Mult. Scler."},{"issue":"10","key":"10.1016\/j.jad.2015.08.040_bib17","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1212\/WNL.38.10.1631","article-title":"Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis","volume":"38","author":"Minden","year":"1988","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jad.2015.08.040_bib18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archneur.1990.00530010124031","article-title":"Affective disorders in multiple sclerosis. Review and recommendations for clinical research","volume":"47","author":"Minden","year":"1990","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.jad.2015.08.040_bib19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jpsychores.2012.08.004","article-title":"Multiple sclerosis relapses and depression","volume":"73","author":"Moore","year":"2012","journal-title":"J. Psychosom. Res."},{"issue":"1","key":"10.1016\/j.jad.2015.08.040_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0306-4530(95)00031-3","article-title":"Psychopathological and neuropsychological effects of 8-days\u2019 corticosteroid treatment. A prospective study","volume":"21","author":"Naber","year":"1996","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"10.1016\/j.jad.2015.08.040_bib21","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/jnnp.2009.186874","article-title":"Sleep disturbance and impulsive-compulsive behaviours in Parkinson's disease","volume":"82","author":"O\u2019Sullivan","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2015.08.040_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/797658","article-title":"Stable bipolar patient switched to mania following clinical doses of prednisone","author":"Panwar","year":"2011","journal-title":"Case Rep. Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2015.08.040_bib23","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1191\/1352458503ms960oa","article-title":"Depressive symptoms in a treated multiple sclerosis cohort","volume":"9","author":"Patten","year":"2003","journal-title":"Mult. Scler."},{"issue":"17","key":"10.1016\/j.jad.2015.08.040_bib24","first-page":"495","article-title":"Use of cortisone and ACTH in certain diseases: psychiatric aspects","volume":"25","author":"Rome","year":"1950","journal-title":"Proc. Staff Meet Mayo Clin."},{"issue":"5","key":"10.1016\/j.jad.2015.08.040_bib25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/07357908909041378","article-title":"Corticosteroids in cancer: neuropsychiatric complications","volume":"7","author":"Stiefel","year":"1989","journal-title":"Cancer Invest."},{"issue":"3","key":"10.1016\/j.jad.2015.08.040_bib26","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1176\/ajp.141.3.369","article-title":"Reversible steroid dementia in patients without steroid psychosis","volume":"141","author":"Varney","year":"1984","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2015.08.040_bib27","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1176\/appi.psy.42.6.461","article-title":"Corticosteroid-induced psychotic and mood disorders: diagnosis defined by DSM-IV and clinical pictures","volume":"42","author":"Wada","year":"2001","journal-title":"Psychosomatics"},{"issue":"4","key":"10.1016\/j.jad.2015.08.040_bib28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4088\/JCP.v61n0404","article-title":"Recurrent cases of corticosteroid induced mood disorder: clinical characteristics and treatment","volume":"61","author":"Wada","year":"2000","journal-title":"J. Clin. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032715305164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032715305164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T03:54:15Z","timestamp":1537415655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032715305164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":28,"alternative-id":["S0165032715305164"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2015.08.040","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Depression and hypomania symptoms are associated with high dose corticosteroids treatment for MS relapses","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2015.08.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}